Table 9.
Urinary biomarkers
| Biomarker | Number and volume of aliquots |
|---|---|
| 4-Aminobiphenyl, 3-Aminobiphenyl, |
2 aliquots of 12 mL each |
| o-Toluidine, 2-Aminonaphthalene | |
| OH-PAHs suite |
2 aliquots of 12 mL each |
| Nicotine + 5 |
2 aliquots of 6 mL each |
| 3-HPMA, HMPMA, CEMA |
2 aliquots of 3 mL each |
| MHBMA |
2 aliquots of 3 mL each |
| Total NNAL, NNN, NAB and NAT |
2 aliquots of 10 mL each |
| F2-isoprostane (8-iso-PGF2 Type III) |
2 aliquots of 6 mL each |
| F2-isoprostane (8-iso-PGF2 Type VI) |
2 aliquots of 6 mL each |
| 11-dehydrothromboxane B2 |
2 aliquots of 3 mL each |
| Urine mutagenicity |
1 aliquots of 300 mL each |
| 8-OHdG |
2 aliquots of 1.5 mL each |
| Cis-thymidine glycol | 2 aliquots of 1.5 mL each |
OH-PAH, phenolic polycyclic aromatic hydrocarbons.3-HPMA, 3-Hydroxypropylmercapturic acid.
HMPMA, 3-hydroxy-1-methylpropylmercapturic acid. CEMA, 2-cyanoethylmercapturic acid.
MHBMA, monohydroxy-3-butenylmercapturic acid. NNAL, 4-(methylnitrosamino-1-(3-pyridyl)-1-butanol.
NNN, N-nitrosonornicotine. NAB, N-nitrosoanabasine. NAT, N-nitrosoanatabine.
8-OhdG, 8-Oxo-2′-deoxyguanosine.